Literature DB >> 23377156

Contrast-induced nephropathy: pathophysiology and preventive strategies.

Ann L Jorgensen1.   

Abstract

Contrast-induced nephropathy is the third most common cause of hospital-acquired renal failure, after decreased renal perfusion and nephrotoxic medications. Identification of patients at risk and implementation of preventive strategies can decrease the incidence of this nephropathy. Prevention strategies focus on counteracting vasoconstriction, enhancing blood flow through the nephron, and providing protection against injury by oxygen free radicals. Knowledge of the adverse effects associated with infusion of contrast media, identification of patients at risk for contrast-induced nephropathy, and application of evidence-based prevention strategies allow nurses to assist in the prevention of contrast-induced nephropathy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377156     DOI: 10.4037/ccn2013680

Source DB:  PubMed          Journal:  Crit Care Nurse        ISSN: 0279-5442            Impact factor:   1.708


  35 in total

1.  Atorvastatin alleviates iodinated contrast media-induced cytotoxicity in human proximal renal tubular epithelial cells.

Authors:  Gai-Ling Liu; Rong Lei; Shao-Bin Duan; Mi-Mi Tang; Min Luo; Qian Xu
Journal:  Exp Ther Med       Date:  2017-08-01       Impact factor: 2.447

2.  Astaxanthin attenuates contrast agent-induced acute kidney injury in vitro and in vivo via the regulation of SIRT1/FOXO3a expression.

Authors:  Nana Liu; Jing Chen; Dongmei Gao; Wenhua Li; Di Zheng
Journal:  Int Urol Nephrol       Date:  2018-01-24       Impact factor: 2.370

3.  The incidence of contrast medium-induced nephropathy following endovascular aortic aneurysm repair: assessment of risk factors.

Authors:  Serkan Guneyli; Halil Bozkaya; Celal Cinar; Mehmet Korkmaz; Soner Duman; Turker Acar; Yigit Akin; Mustafa Parildar; Ismail Oran
Journal:  Jpn J Radiol       Date:  2015-03-07       Impact factor: 2.374

Review 4.  Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes.

Authors:  Konstantinos Makris; Loukia Spanou
Journal:  Clin Biochem Rev       Date:  2016-05

5.  Retracted Article: High-throughput metabolomics identifies serum metabolic signatures in acute kidney injury using LC-MS combined with pattern recognition approach.

Authors:  Hai-Hong Li; Jian-Liang Pan; Su Hui; Xiao-Wei Ma; Zhi-Long Wang; Hui-Xin Yao; Jun-Feng Wang; Hong Li
Journal:  RSC Adv       Date:  2018-04-18       Impact factor: 4.036

Review 6.  Contrast-induced nephropathy; A literature review.

Authors:  Jafar Golshahi; Hamid Nasri; Mojgan Gharipour
Journal:  J Nephropathol       Date:  2014-04-01

7.  Inverse correlation between left ventricular end-diastolic pressure and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.

Authors:  Guoqiang Gu; Hanghang Xing; Yaqing Zhou; Wei Cui
Journal:  Clin Exp Nephrol       Date:  2017-12-01       Impact factor: 2.801

8.  Elevation of preoperative cystatin C as an early predictor of contrast-induced nephropathy in patients receiving percutaneous coronary intervention.

Authors:  Guoqiang Gu; Ningning Yu; Yaqing Zhou; Wei Cui
Journal:  Singapore Med J       Date:  2022-08       Impact factor: 3.331

9.  Efficacy of simvastatin on carotid atherosclerotic plaque and its effects on serum inflammatory factors and cardiocerebrovascular events in elderly patients.

Authors:  Huali Zhang; Min Jiang; Hong Hou; Qin Li
Journal:  Exp Ther Med       Date:  2021-06-02       Impact factor: 2.447

10.  Novel Nanoliposomes Alleviate Contrast-Induced Nephropathy by Mediating Apoptosis Response in New Zealand Rabbits.

Authors:  Peng Zhang; Xue Zhang; Jing Zhang; Yanqiu Song; Ting Liu; Zhican Zeng; Xiaofeng Fu; Han Fu; Hong Zhang; Qin Qin; Naikuan Fu; Zhigang Guo
Journal:  Front Mol Biosci       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.